Driehaus Capital Management’s Evolent Health EVH Stock Holding History

Driehaus Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-57,400	Closed	-$1.15M	–	429
2018 Q4	$1.15M	Buy	57,400 +3,000	+6%	+$69.4K	0.05%	266
2018 Q3	$1.54M	Sell	54,400 -10,300	-16%	-$246K	0.05%	312
2018 Q2	$1.36M	Buy	+64,700	New	+$1.22M	0.05%	309
2017 Q3	–	Sell	-25,988	Closed	-$659K	–	511
2017 Q2	$659K	Sell	25,988 -252	-1%	-$6.06K	0.02%	386
2017 Q1	$585K	Buy	+26,240	New	+$504K	0.02%	416
2016 Q4	–	Sell	-160,104	Closed	-$3.94M	–	570
2016 Q3	$3.94M	Sell	160,104 -7,530	-4%	-$176K	0.13%	161
2016 Q2	$3.22M	Buy	+167,634	New	+$2.3M	0.11%	189

Other funds holding EVH

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Driehaus Capital Management's EVH Position: Q1 2019 in Review

Driehaus Capital Management sold out of Evolent Health (EVH) in Q1 2019, closing a stake of 57,400 shares — an estimated $1.15M sold.

Driehaus Capital Management first reported a position in EVH in Q2 2016 and held it in 7 quarters. The position peaked at $3.94M in Q3 2016. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2019.

Driehaus Capital Management reported no remaining Evolent Health position as of Q1 2019 after selling out during the quarter.
Driehaus Capital Management sold 57,400 Evolent Health shares in Q1 2019, an estimated $1.15M.
Driehaus Capital Management first reported a position in Evolent Health in Q2 2016 and held it in 7 quarters.
Driehaus Capital Management's Evolent Health position peaked at $3.94M in Q3 2016.
192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2019.

Based on Driehaus Capital Management's 13F filing for Q1 2019, filed 15 May 2019.